GO
Loading...

Will Allergan Raise It's Guidance?

Wednesday, 26 Oct 2011 | 6:50 PM ET

David Pyott, Allergan chairman/CEO, discusses the company's earnings, and products in the big pharma pipeline, with Mad Money's Jim Cramer.